loading

Finanzdaten der Dyne Therapeutics Inc-Aktie (DYN)

Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums 2025-06-30 2025-03-31 2024-12-31 2024-09-30 2024-06-30
Periodenlänge 3 Monate 3 Monate 3 Monate 3 Monate 3 Monate
Revenues
-
- - - -
Operating Expenses
5.38%
115.79
122.37 97.11 105.66 71.96
Operating Income/Loss
5.38%
-115.79
-122.37 -97.11 -105.66 -71.96
Income/Loss From Continuing Operations Before Tax
3.90%
-110.86
-115.36 -89.54 -97.12 -65.10
Income/Loss From Continuing Operations After Tax
3.90%
-110.86
-115.36 -89.54 -97.12 -65.10
Net Income/Loss
3.90%
-110.86
-115.36 -89.54 -97.12 -65.10
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Earnings Per Share
7.62%
-0.97
-1.05 -0.88 -0.96 -0.70
Diluted Earnings Per Share
7.62%
-0.97
-1.05 -0.88 -0.96 -0.70
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$24.65
price up icon 0.94%
$85.04
price down icon 1.72%
$26.20
price up icon 0.73%
$110.88
price up icon 0.10%
$131.88
price down icon 0.54%
biotechnology ONC
$313.67
price down icon 0.10%
Kapitalisierung:     |  Volumen (24h):